吡啶
激酶
药物发现
化学
部分
细胞周期蛋白依赖激酶
组合化学
药理学
癌症研究
立体化学
细胞
药物化学
生物化学
生物
细胞周期
作者
Richa Goel,Vijay Luxami,Kamaldeep Paul
标识
DOI:10.2174/1568026616666160414122644
摘要
Imidazo[1,2-a]pyridine has been shown to be an important biologically active moiety. This review is a compilation of the scattered output of results of the anticancer activities of the imidazo[1,2-a]pyridine system since 2001, which have been classified as inhibition of CDK, VEGFR, PI3K, EGFR, RGGT etc. along with inhibition against different tumor cell lines. Various imidazo[1,2-a]pyridine based analogues have been used as lead molecules and are now under human clinical trials. This review will help the wider scientific community in the area of drug discovery of imidazo[1,2-a]pyridines as novel anticancer agents. Keywords: Antitubulins, Antitumor, Cyclin dependent kinase inhibitors, Imidazo[1, 2-a]pyridine, Phosphoinositide-3-kinase inhibitors, Topoisomerase-II inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI